Q1 2025 Management View CEO Henry Fernandez highlighted MSCI's financial performance with 10% organic revenue growth, 11% adjusted EBITDA growth, and a 14% increase in adjusted EPS. The company ...

S4 Capital’s business is smaller and less diverse than that of larger advertising holding companies, making it more susceptible to economic downturns and higher volatility in its operating and credit ...

Q1 2025 Management View Jim Davis, CEO, reported a 12% revenue growth in Q1 2025, attributed to contributions from acquisitions, large enterprise accounts, and the advanced diagnostics portfolio.

While total sales growth decelerated for 3M's Safety & Industrial segment, they ticked up sequentially in organic growth.

Kotak Institutional Equities initiated coverage on Dr Agarwal's Health Care with an 'Add' rating and Rs 425 target, citing ...

We see a compelling investment case in Ducommun, a military and commercial aerospace supplier. Click here for our thesis on ...

Aryzta reported higher first-quarter revenue driven by growth in the Europe segment and said it was on track to meet its low to mid-single digit organic growth target for this year.

Xvivo Perfusion AB (XVIPF) reports strong financial performance with significant growth in thoracic sales and strategic ...

Omnicom, working toward finalising the acquisition of competitor IPG later this year, is developing plans for integrating its ...

Brokerage firms said that HCL Tech is expected to post muted sequential top and bottom-line growth, mainly due to seasonal ...

Marsh McLennan posted organic growth of 4% in Q1 2025 as adjusted earnings per share grew to $3.06. The 4% Q1 figure represented a 3-point deceleration on the 7% reported in Q4 2024 and a drop of 5 ...

Britain's Rentokil Initial on Thursday said its organic revenue rose nearly 2% in the first quarter, helped by broad strength in its international pest control business that helped offset sluggishness ...